FDA Inspection 926013 — ABX Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien GmbH
The FDA completed an inspection of ABX Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien GmbH on Apr 30, 2015 in Radeberg. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 30, 2015
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Radeberg (Germany)